Mirae Asset Global ETFs Holdings
HAE icon

Mirae Asset Global ETFs Holdings’s Haemonetics HAE Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Sell
21,727
-325
-1% -$20.9K ﹤0.01% 1363
2026
Q1 		$1.24M Sell
22,052
-343
-2% -$22.3K ﹤0.01% 1416
2025
Q4 		$1.79M Sell
22,395
-5
-0% -$336 ﹤0.01% 1203
2025
Q3 		$1.09M Sell
22,400
-5,236
-19% -$324K ﹤0.01% 1437
2025
Q2 		$2.06M Sell
27,636
-1,905
-6% -$126K ﹤0.01% 1081
2025
Q1 		$1.88M Buy
29,541
+971
+3% +$66K ﹤0.01% 1176
2024
Q4 		$2.23M Buy
28,570
+1,084
+4% +$87.1K ﹤0.01% 1075
2024
Q3 		$2.21M Buy
27,486
+1,454
+6% +$117K 0.01% 1069
2024
Q2 		$2.15M Buy
+26,032
New +$2.29M 0.01% 1047

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's HAE Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Haemonetics (HAE) stake by 1.5% in Q2 2026, selling an estimated $20.9K and leaving 21,727 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1363.

Mirae Asset Global ETFs Holdings first reported a position in HAE in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.23M in Q4 2024. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 21,727 shares of Haemonetics worth $1.63M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 325 Haemonetics shares in Q2 2026, an estimated $20.9K.
  • Haemonetics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1363 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Haemonetics in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Haemonetics position peaked at $2.23M in Q4 2024.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.